Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Wang, Yu  [Clear All Filters]
2020
Liu S-N, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute GVHD: updated experienced from a large-scale study. Am J Hematol. 2020.
Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transplant. 2020.
Xuan L, Wang Y, Huang F, Fan Z, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, et al. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial. Lancet Oncol. 2020.
2021
Wang Y, Liu X, Hu T, Li X, Chen Y, Xiao G, Huang J, Chang Y, Zhu Y, Zhang H, et al. Astragalus saponins improves stroke by promoting the proliferation of neural stem cells through phosphorylation of Akt. J Ethnopharmacol. 2021:114224.
Xu L-P, Yu Y, Cheng Y-F, Zhang Y-Y, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, et al. Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation. Br J Haematol. 2021.
Yu L, Myers G, Ku C-J, Schneider E, Wang Y, Singh SA, Jearawiriyapaisarn N, White A, Moriguchi T, Khoriaty R, et al. An erythroid to myeloid cell fate conversion is elicited by LSD1 inactivation. Blood. 2021.
Yan T, Rao D, Chen Y, Wang Y, Zhang Q, Wu S. Magnetic Nanocomposite Hydrogel with Tunable Stiffness for Probing Cellular Responses to Matrix Stiffening. Acta Biomater. 2021.
Sun Y-Q, Xu L-P, Liu K-Y, Zhang X-H, Yan C-H, Jin J, Huang X-J, Wang Y. Pre-transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors. Cancer Commun (Lond). 2021.
Zhao P, Wu Y, He Y, Chong S, Qu Q, Deng R, Sun X, Huang Q-S, Liu X, Zhu X, et al. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood Adv. 2021.
Cao L-Q, Zhou J-R, Zhang X-H, Xu L-P, Wang Y, Chen Y-H, Chen H, Chen Y, Han W, Yan C-H, et al. A scoring system for predicting the prognosis of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021.
Han T, Sun Y, Liu Y, Yan C, Wang Y, Xu L, Liu K, Huang X, Zhang X. Second unmanipulated allogeneic transplantation could be used as a salvage option for patients with relapsed acute leukemia post-chemotherapy plus modified donor lymphocyte infusion. Front Med. 2021.
Wang J-Z, Huang X-J, Zhang Y-Y, Tang F-F, Han T-T, Mo X-D, Sun Y-Q, Chen Y-H, Wang Y, Zhang X-H, et al. Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia. Chin Med J (Engl). 2021;134(20):2518-2520.
2022
Zhu W, Chen L, Wu Z, Li W, Liu X, Wang Y, Guo M, Ito Y, Wang L, Zhang P, et al. Bioorthogonal DOPA-NGF activated tissue engineering microunits for recovery from traumatic brain injury by microenvironment regulation. Acta Biomater. 2022.
Li S-Q, Xu L, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Complement of an LSC-based MRD assay to the traditional MFC method for relapse prediction of AML: a prospective study. Blood. 2022.
Guo J, Wang Y, Zhang H, Zhao Y. Conductive materials with elaborate micro/nanostructures for bioelectronics. Adv Mater. 2022:e2110024.
Wang Y, Mo X, Cheng Y, Chen Y, Lv M, Wang F, Yan C, Han W, Chen H, Xu L, et al. Effects of CD34 cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease. Int J Lab Hematol. 2022.
Deng J, Li M, Li Z, Meng F, Gao J, Li J, Wang Y, Zhang LC, Tang PF. Establishment and characterization of an induced pluripotent stem cell line CPGHi004-A from peripheral blood mononuclear cells of a healthy adult. Stem Cell Res. 2022;59:102656.
Wang Y, Sun X, Yang Q, Yin L. Exosomes from bone mesenchymal stem cells alleviate mifepristone-induced human endometrial stromal cell injury by inhibiting TLR3 via delivering miR-941. Physiol Int. 2022.
Liu Y, Wang Y, Li X, Jia Y, Wang J, Ao X. FOXO3a in cancer drug resistance. Cancer Lett. 2022:215724.
Lin F, Zuo Y, Zhang Y, Cheng Y, Han T, Mo X, Suo P, Sun Y, Tang F, Wang F, et al. The impact of pre-transplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescents. Pediatr Blood Cancer. 2022:e29845.
Deng R-X, Zhu X-L, Zhang A-B, He Y, Fu H-X, Wang F-R, Mo X-D, Wang Y, Zhao X-Y, Zhang Y-Y, et al. Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients. Transplant Cell Ther. 2022.
Liu J, Wu D, Liu Q, Chang Y, Xu Y, Huang F, Huang X, Wang Y. More than two courses of consolidation therapy pre-transplantation benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts: a multicenter study. Chin Med J (Engl). 2022.
Ma L, Wei X, Ma W, Liu Y, Wang Y, He Y, Jia S, Wang Y, Luo W, Liu D, et al. Neural Stem Cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem Cells in Therapy of Spinal Bifida Aperta. Stem Cells Transl Med. 2022.
Zheng Y, Zhou J, Wang Y, Fan F, Liu S, Wang Y. Neural Stem/Progenitor Cell Transplantation in Parkinson's Rodent Animals: A Meta-Analysis and Systematic Review. Stem Cells Transl Med. 2022.
Luo X-Y, Kong Y, Lv M, Mo X-D, Wang Y, Xu L-P, Zhang X-H, Huang X-J, Tang F-F. The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2022.

Pages